The Adelaide China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.

A study into the impact of state-funded vaccination programs for Australian children under five years has found those attending medical practices in the wealthiest areas were more likely to receive the vaccine.

Improving human health is the aim of $11.6 million in new research awarded to the University of Adelaide today, including a major project to investigate tackling two serious infections with one vaccine.